Primaquine Phosphate is the phosphate salt form of primaquine, a synthetic, 8-aminoquinoline derivative with antimalarial properties. Although its mechanism of action is unclear, primaquine bind to and alter the properties of protozoal DNA. This agent eliminates tissue (exo-erythrocytic) malarial infection, preventing the development of the erythrocytic forms of the parasite which are responsible for relapses in Plasmodium vivax and ovale malaria. Primaquine is active against late hepatic stages (hypnozoites, schizonts).
Collision Cross Section161.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Physicochemical properties
Melting point
205 · 205-206 °C (dec.)(lit.)
storage temp.
2 · 2-8°C
solubility
50 mg/mL, · water: soluble50mg/mL, clear, orange to red
form
Solid
color
Red brown to orange
Water Solubility
moderately soluble
Merck
13 · 13,7833
BRN
3812133 · 3812133
BCS Class
1 · 1 (CLogP), 3 (LogP)
Stability
Stable. Incompatible with strong oxidizing agents.
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
GHS classification
GHS Classification · 4 items
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory.
Hazard information
Other Safety InformationIMAP assessments - 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate(1:2): Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (100%)
Toxicology
Drug Induced Liver Injury · 6 items
Drug Induced Liver Injury Rank (DILIrank 2.0)
Primaquine phosphate
vNo-DILI-concern
0
No match
DOI:10.1016/j.drudis.2016.02.015
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Safety data
F
10
PPE
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
wgk
3
rtecs
VA9660000
ridadr
UN 2811 6.1/PG 3
hs_code
29334900
Chemistry & industry
Pharmacology
FDA Pharmacological Classification · 2 items
PRIMAQUINE PHOSPHATE
Antimalarial [EPC]
MeSH Pharmacological ClassificationAgents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
Applications · 3 items
Usesacetylcholinesterase inhibitor
UsesPrimaquine diphosphate is an established antimalarial drug used in the treatment of persistent liver forms of P. vivax or P. ovale infection for its ability to kill late-stage gametocytes and hypnozoites. In historical terms, this aminoquinoline was the stimulus for the discovery of glucose-6-phosphate (G6P) dehydrogenase deficiency as it induced hemolytic anemia in patients lacking the G6P-metabolizing enzyme.